Caraco Pharmaceutical Laboratories and DUSA Pharmaceuticals Announce Early Termination of the Hart-Scott-Rodino Waiting Period Relating to Tender Offer
December 05, 2012 12:00 ET
|
DUSA Pharmaceuticals, Inc.
DETROIT and WILMINGTON, Mass., Dec. 5, 2012 (GLOBE NEWSWIRE) -- Caraco Pharmaceutical Laboratories, Ltd. ("CPL"), a wholly owned subsidiary of Sun Pharmaceutical Industries Limited ("Sun Pharma"), and...
Sun Pharma to Acquire DUSA Pharmaceuticals, Inc.
November 08, 2012 06:36 ET
|
DUSA Pharmaceuticals, Inc.
WILMINGTON, Mass. and MUMBAI, India, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Sun Pharmaceutical Industries Limited ((Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715)) (together with its...
DUSA Pharmaceuticals, Inc.(R) to Host Third Quarter 2012 Corporate Highlights and Financial Results Webcast and Conference Call
November 05, 2012 06:30 ET
|
DUSA Pharmaceuticals, Inc.
WILMINGTON, Mass., Nov. 5, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc. (Nasdaq:DUSA), announces that its third quarter 2012 corporate highlights and financial results press release will be...
DUSA Pharmaceuticals Demonstrates Positive Results in Phase 2 Actinic Keratoses Extremities Study
September 13, 2012 06:30 ET
|
DUSA Pharmaceuticals, Inc.
Levulan® PDT Using Occlusion Results in an 89% AK Lesion Clearance Rate
WILMINGTON, Mass., Sept. 13, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology...
DUSA Pharmaceuticals to Present at the Rodman & Renshaw 14th Annual Healthcare Conference
September 04, 2012 08:00 ET
|
DUSA Pharmaceuticals, Inc.
WILMINGTON, Mass., Sept. 4, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT),...
DUSA Pharmaceuticals Reports Second Quarter 2012 Corporate Highlights and Financial Results
August 02, 2012 06:30 ET
|
DUSA Pharmaceuticals, Inc.
Quarterly Domestic Kerastick® Revenues Up 22% Year-Over-Year;
Quarterly Product Gross Margins Up 21% Year-Over-Year
Conference call and audio webcast will be held today, August 2nd, at...
DUSA Pharmaceuticals, Inc.(R) to Host Second Quarter 2012 Corporate Highlights and Financial Results Webcast and Conference Call
July 26, 2012 06:30 ET
|
DUSA Pharmaceuticals, Inc.
WILMINGTON, Mass., July 26, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc. (Nasdaq:DUSA) announces that its second quarter 2012 corporate highlights and financial results press release will be...
DUSA Pharmaceuticals to Present at the Inaugural Marcum MicroCap Conference on June 20th in New York City
June 15, 2012 08:30 ET
|
DUSA Pharmaceuticals, Inc.
NEW YORK, June 15, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a specialty pharmaceutical company focused primarily on the development and marketing of its Levulan®...
DUSA Pharmaceuticals, Inc.(R) to Webcast Annual Meeting of Shareholders
June 07, 2012 06:30 ET
|
DUSA Pharmaceuticals, Inc.
WILMINGTON, Mass., June 7, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc. (Nasdaq:DUSA) announces that it will host a live audio webcast of its Annual Meeting of Shareholders at 11:00am EDT on...
DUSA Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference
May 31, 2012 08:30 ET
|
DUSA Pharmaceuticals, Inc.
WILMINGTON, Mass., May 31, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT),...